BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 20962677)

  • 21. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
    Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2018; 9():2207. PubMed ID: 30349527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of graft versus host disease (GVHD) by photopheresis?
    Schooneman F; Claise C
    Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
    Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
    Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on extracorporeal photochemotherapy for graft-versus-host disease treatment.
    Kanold J; Messina C; Halle P; Locatelli F; Lanino E; Cesaro S; Deméocq F;
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S69-71. PubMed ID: 15812535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis.
    Greinix HT; Tanew A
    Curr Probl Dermatol; 2012; 43():116-31. PubMed ID: 22377925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.
    Greinix HT; Knobler RM; Worel N; Schneider B; Schneeberger A; Hoecker P; Mitterbauer M; Rabitsch W; Schulenburg A; Kalhs P
    Haematologica; 2006 Mar; 91(3):405-8. PubMed ID: 16531267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients.
    Halle P; Paillard C; D'Incan M; Bordigoni P; Piguet C; De Lumley L; Stephan JL; Berger M; Rapatel C; Deméocq F; Kanold J
    J Hematother Stem Cell Res; 2002 Jun; 11(3):501-12. PubMed ID: 12183835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracorporeal photopheresis in chronic graft-versus-host disease.
    Foss FM; Gorgun G; Miller KB
    Bone Marrow Transplant; 2002 May; 29(9):719-25. PubMed ID: 12040467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shaping of CD56
    Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2019; 10():547. PubMed ID: 30949182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
    Kaloyannidis P; Mallouri D
    Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Experience in Extracorporeal Photopheresis for Adults with Graft-versus-Host Disease.
    Asensi Cantó P; Sanz Caballer J; Sopeña Pell-Ilderton C; Solís Ruiz J; Lloret Madrid P; Villalba Montaner M; Facal Malvar A; Chorão P; Guerreiro M; Balaguer Roselló A; Montoro Gómez J; Santiago Balsera M; Solves Alcaína P; Sanz Alonso MÁ; De la Rubia Comos J; Gómez-Seguí I
    Transplant Cell Ther; 2023 Dec; 29(12):765.e1-765.e8. PubMed ID: 37703997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.
    Jagasia M; Greinix H; Robin M; Das-Gupta E; Jacobs R; Savani BN; Engelhardt BG; Kassim A; Worel N; Knobler R; Russell N; Socie G
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1129-33. PubMed ID: 23623892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
    Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
    Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
    Greinix HT; Worel N; Knobler R
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1747-8; author reply 1749. PubMed ID: 20601039
    [No Abstract]   [Full Text] [Related]  

  • 38. Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.
    Del Fante C; Scudeller L; Viarengo G; Bernasconi P; Perotti C
    Transfusion; 2012 Sep; 52(9):2007-15. PubMed ID: 22320219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
    Greinix HT; Worel N; Just U; Knobler R
    Transfus Apher Sci; 2014 Jun; 50(3):349-57. PubMed ID: 24780392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
    Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
    Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.